{"id":"TC.138","name":"Tax credit for orphan drug research","popular_name":null,"objective":"The baseline tax system would not allow credits for particular activities, investments, or industries. In contrast, under current law drug firms can claim a tax credit of 25 percent of the costs for clinical testing required by the Food and Drug Administration for drugs that treat rare physical conditions or rare diseases.","sam_url":null,"usaspending_url":null,"grants_url":null,"top_agency_name":"Department of the Treasury","sub_agency_name":"Internal Revenue Service (IRS)","assistance_types":["Tax Expenditures"],"beneficiary_types":[],"applicant_types":[],"categories":["Tax Expenditures - Health"],"obligations":null,"other_program_spending":[{"x":"2023","outlays":0.0,"forgone_revenue":1740000000.0},{"x":"2024","outlays":0.0,"forgone_revenue":1930000000.0},{"x":"2025","outlays":0.0,"forgone_revenue":2150000000.0}],"outlays":null,"results":[],"authorizations":[],"program_type":"tax_expenditure","is_subpart_f":null,"rules_regulations":null,"improper_payments":[],"gwo":null,"pons":[]}